Picture of Adaptive Biotechnologies logo

ADPT Adaptive Biotechnologies News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Adaptive Biotechnologies Corp reports results for the quarter ended in December - Earnings Summary

* Adaptive Biotechnologies Corp  ADPT.OQ  reported a
quarterly
adjusted loss of 30 cents​​ per share for the quarter ended in
December, lower than the same quarter last year, when the
company reported EPS of -28 cents.  The mean expectation of
eight analysts for the quarter was for a loss of 33 cents per
share. Wall Street expected results to range from -36 cents
to -30 cents per share.
    * Revenue fell 17.1% to $45.78 million from a year ago;
analysts
expected $48.46 million. 
    * Adaptive Biotechnologies Corp's reported EPS for the
quarter was
a loss of 48 cents​.
    * The company reported a quarterly loss of $69.44 million.
    * Adaptive Biotechnologies Corp shares had fallen by 26.1%
this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 19.9%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Adaptive
Biotechnologies Corp is $8.50 
This summary was machine generated from LSEG data February 14 at
11:15 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.33          -0.30          Beat
 Sep. 30 2023      -0.34          -0.35          Missed
 Jun. 30 2023      -0.35          -0.33          Beat
 Mar. 31 2023      -0.38          -0.40          Missed

Recent news on Adaptive Biotechnologies

See all news